ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,568, issued on Oct. 28, was assigned to Academy of Military Medical Science, PLA (Bejing, China).

"Monoclonal antibody 2G1 for broad-spectrum neutralization of ebola viruses and application thereof" was invented by Wei Chen (Beijing), Changming Yu (Beijing), Pengfei Fan (Beijing), Xiangyang Chi (Beijing), Guanying Zhang (Beijing), Jianmin Li (Beijing), Lihua Hou (Beijing), Junjie Xu (Beijing), Ting Fang (Beijing), Shipo Wu (Beijing), Yi Chen (Beijing), Zhengshan Chen (Beijing), Yujiao Liu (Beijing) and Meirong Wang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a monoclonal antibody 2G1 against an Ebola glycoprotein GP2 subunit...